COMMD9: Potential Drug Target and Biomarker (G29099)

Target Name: COMMD9

NCBI ID: G29099

COMMD9

COMMD9: Potential Drug Target and Biomarker

COMMD9 (COMMD9 variant 1) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and kidneys. It is a key regulator of cell growth, differentiation, and survival, and is involved in many important cellular processes. Despite its importance, little is known about COMMD9 and its potential as a drug target or biomarker. In this article, we will explore the biology of COMMD9, its potential drug target status, and its potential as a biomarker for various diseases.

Background

COMMD9 is a member of the commensal protein family, which includes proteins that are expressed in many different tissues and are involved in various cellular processes. The commensal protein family is characterized by the presence of a unique C-terminal region that is involved in various signaling pathways.

COMMD9 is expressed in a wide range of tissues throughout the body, including the brain, lungs, heart, and kidneys. It is involved in many important cellular processes, including cell growth, differentiation, and survival.

Potential Drug Target

COMMD9 is a potential drug target due to its involvement in various cellular processes that are important for human health. One of the key functions of COMMD9 is its role in cell growth and differentiation. COMMD9 is involved in the regulation of cell size and shape, as well as the maintenance of cellular structure and stability.

COMMD9 is also involved in the regulation of cell survival and stress resistance. It plays a key role in the regulation of cell apoptosis, which is a natural process that helps the body to remove damaged or dysfunctional cells.

In addition to its role in cell survival and growth, COMMD9 is also involved in the regulation of inflammation. It is involved in the regulation of the immune response, and is thought to play a key role in the regulation of inflammation that can be harmful to the body.

Potential Biomarker

COMMD9 may also be a potential biomarker for various diseases. For example, it may be a useful biomarker for cancer, as it is involved in the regulation of cell growth and survival. In addition, COMMD9 may be a useful biomarker for cardiovascular disease, as it is involved in the regulation of cell survival and stress resistance.

COMMD9 may also be a useful biomarker for neurodegenerative diseases, as it is involved in the regulation of cell survival and stress resistance. These diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of various symptoms.

Conclusion

In conclusion, COMMD9 is a protein that is expressed in various tissues throughout the body and is involved in many important cellular processes. Its potential as a drug target or biomarker is due to its involvement in various cellular processes that are important for human health. Further research is needed to fully understand the role of COMMD9 in the regulation of cellular processes and its potential as a drug target or biomarker.

Protein Name: COMM Domain Containing 9

Functions: May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits (PubMed:23637203)

The "COMMD9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COMMD9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets